Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Time Course of Drug Effect
Angle Closure Glaucoma: Treatment
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 26, 2026

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
Published on: March 23, 2016
Eric Denion1, Frédérique Charlot, Guillaume Béraud
11Centre Ophtalmologique du Pays des Olonnes (COPO), Les Sables-d'Olonne, France 2Service d'Ophtalmologie, Polyclinique de la Baie, Saint-Martin-des-Champs, France 3Médecine Interne et Maladies Infectieuses, Poitiers, France 4Université Droit et Santé Lille 2, Lille, France 5Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Hasselt, Belgium.
A 5-minute wait between administering eye drops increases their combined effect, contrary to previous findings. This study confirms a detectable additive effect, suggesting optimal eye drop timing for enhanced therapeutic outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: